– USA, NM – Mercury Bio, a biotech company commercializing an innovative and highly disruptive drug delivery platform, today announced the appointment of Mike Rice to its board of directors.
Mike Rice said, “I am honored to join the Mercury board at this exciting inflection point. With a strong leadership team, as well as world class researchers and manufacturing experts, Mercury Bio is poised to significantly disrupt the current state of delivery of various biologics targeting cancer and other large disease states through the use of their proprietary extracellular vesicles (yEV™) platform.”
About Mike Rice
During his 17+ year tenure at BioLife Solutions, Mike Rice led the company’s strategy formation and execution to create a new life sciences tools product category centered on clinical grade biopreservation media. Today, BioLife’s flagship proprietary media products are embedded in nearly 1,000 customer applications, including most of the currently approved cell therapies, and a significant number of active clinical trials for novel cell and gene therapies.
About Mercury Bio
Sparked by scientific breakthroughs in genomic research, Mercury Bio is developing a next-generation biomolecular drug delivery platform. Using a novel system for drug encapsulation in natural vesicles, their technology enhances drug efficacy while reducing side effects by employing cell-specific targeting. The result is an advanced drug delivery system in a scalable, low-cost production platform that will unlock the potential of RNA therapeutics and small molecule drugs.
SOURCE: https://www.mercurybio.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
